PLoS One by Zelner, Jonathan L. et al.
Linking Time-Varying Symptomatology and Intensity of
Infectiousness to Patterns of Norovirus Transmission
Jonathan L. Zelner1,3*, Benjamin A. Lopman2, Aron J. Hall2, Sebastien Ballesteros1, Bryan T. Grenfell1,3
1 Department of Ecology and Evolutionary Biology, Princeton University, Princeton, New Jersey, United States of America, 2 Epidemiology Branch, Division of Viral
Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America, 3 Fogarty
International Center, National Institutes of Health, Bethesda, Maryland, United States of America
Abstract
Background: Norovirus (NoV) transmission may be impacted by changes in symptom intensity. Sudden onset of vomiting,
which may cause an initial period of hyper-infectiousness, often marks the beginning of symptoms. This is often followed
by: a 1–3 day period of milder symptoms, environmental contamination following vomiting, and post-symptomatic
shedding that may result in transmission at progressively lower rates. Existing models have not included time-varying
infectiousness, though representing these features could add utility to models of NoV transmission.
Methods: We address this by comparing the fit of three models (Models 1–3) of NoV infection to household transmission
data from a 2009 point-source outbreak of GII.12 norovirus in North Carolina. Model 1 is an SEIR compartmental model,
modified to allow Gamma-distributed sojourn times in the latent and infectious classes, where symptomatic cases are
uniformly infectious over time. Model 2 assumes infectiousness decays exponentially as a function of time since onset, while
Model 3 is discontinuous, with a spike concentrating 50% of transmissibility at onset. We use Bayesian data augmentation
techniques to estimate transmission parameters for each model, and compare their goodness of fit using qualitative and
quantitative model comparison. We also assess the robustness of our findings to asymptomatic infections.
Results: We find that Model 3 (initial spike in shedding) best explains the household transmission data, using both
quantitative and qualitative model comparisons. We also show that these results are robust to the presence of
asymptomatic infections.
Conclusions: Explicitly representing explosive NoV infectiousness at onset should be considered when developing models
and interventions to interrupt and prevent outbreaks of norovirus in the community. The methods presented here are
generally applicable to the transmission of pathogens that exhibit large variation in transmissibility over an infection.
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Introduction
A recent spike in the number and severity of Norovirus (NoV)
outbreaks worldwide [1] has underscored the rising costs of NoV
transmission in both public health and economic terms. Because
NoV transmission is often so explosive that a small number of
isolated cases may touch off a large outbreak (e.g. [2–5]) the
development of effective interventions necessitates an understand-
ing of how each stage of infection in individual cases impacts
outbreak transmission.
NoV illness is characterized by multiple phases of symptom-
atology: an initial period of explosive vomiting characteristic of
illness onset, followed by 1–3 days of less severe symptoms [6].
Environmental contamination resulting from episodes of vomiting
and diarrhea [2,4,5,7] and post-symptomatic shedding that may
persist for days or weeks after symptoms have resolved [8] have
also been implicated in transmission.
Representing variable infectiousness over the course of a single
infection has been shown to be important for understanding the
transmission dynamics of other pathogens, such as HIV [3,9].
However, despite documented variation in NoV symptom
intensity over time, dynamic models of norovirus transmission
have typically represented infectiousness as homogeneous over the
life of a typical infection (e.g. [7]), or have focused on discrete
events such as vomiting within a classroom [10] or the structure of
contact networks [11] rather than changes in symptom intensity
over the infectious period of a typical case. In this paper, we build
upon earlier work demonstrating the importance of vomiting in
norovirus transmission to consider the impact of including time-
varying intensity of infectiousness on the qualitative and quanti-
tative fit of several models of household-level norovirus transmis-
sion. The methods presented here are also generally applicable to
the outbreak transmission of other enteric and respiratory
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pathogens, where variation in symptom-severity across individuals
and over time can impact transmission dynamics.
We fit three models (Models 1–3), each with a different
representation of the infectious period, to household transmission
data collected subsequent to a 2009 point-source outbreak of
GII.12 norovirus in North Carolina [12] and compare the results
(for a graphical depiction of the household data, see Figure 1). We
begin with a standard compartmental model, denoted Model 1,
which allows for heterogeneous infectious period duration but
assumes homogeneous infectiousness over time. The first alterna-
tive model, Model 2, assumes exponentially decaying infectious-
ness after onset, while the final model, denoted Model 3, allows for
a spike in infectiousness at onset followed by a sharp drop-off in
infectiousness 12 hours after the onset of symptoms. For a
graphical depiction of these models, see Figure 2.
Methods
Data source
In December 2009, more than 200 individuals were sickened by
a GII.12 norovirus outbreak caused by contaminated oysters
served at a North Carolina restaurant. The particular GII.12
strain implicated in this outbreak is estimated to have caused 16%
of reported NoV outbreaks in the United States in 2009–10 [13].
Of the 177 individuals who met the case definition for NoV
infection in this outbreak, 85% reported vomiting at some point
during their infection [12]. Household transmission subsequent to
infection of a household member exposed at the restaurant was
assessed via a phone survey. We designate the first individual in a
household who exhibited symptoms after dining at the restaurant
as the household index case. Household contacts of the index case
reported whether they dined at the point source and whether they
became ill in the 14 days after illness onset in the household index
case. Individuals who dined at the point-source but had symptom
onset after the index case are denoted as exposed non-index cases.
Individuals who were not exposed to the point-source but became
ill during the observation period are referred to as secondary cases.
Those who were not observed to be ill are referred to as non-cases.
For those individuals who reported becoming ill, the approximate
time of illness onset (within 12 hours) was obtained.
Because this work was determined by CDC human subjects
review to be under the auspices of public health response, the
protocol and consent procedure were not formally reviewed by an
IRB, though standard practices of verbal consent and confiden-
tiality were followed. The data were collected as part of a phone
survey, so it was not possible to obtain written consent.
Respondents were assured that all survey questions were voluntary
and confidential. Verbal informed consent was requested and
documented on the survey instrument at the time of the interview.
Figure 1 illustrates the times of illness onset in the 18 households
from this outbreak that had secondary cases. A detailed
epidemiological analysis of this outbreak has been presented
elsewhere [12].
Because index cases were infected at a point-source event rather
than during a large community outbreak that continued through-
out the period assessed by the phone survey, we are able to isolate
the likely source of exposure to other members of the household.
In essence, our household-level transmission data provide multiple
independent realizations of the stochastic transmission process,
since we observed 70 exposed households, each with a distinct
index case. This allows us to examine how time-varying intensity
of infectiousness impacts stochastic variability in transmission
[7,8].
Figure 1. Observations for 18 households with non-index cases. The figure illustrates the time course of infection in the 18 households in
which there was a non-index case who became ill after the onset of symptoms in the index case. Filled boxes indicate an individual who dined at the
point-source and became ill. Filled circles indicate individuals who became ill and did not dine at the point-source. Hollow boxes and circles along the
right margin indicate the number of individuals in the household who did and did not dine at the point source and did not become ill, respectively.
The additional 52 households in the analysis with no secondary cases are not pictured.
doi:10.1371/journal.pone.0068413.g001
Figure 2. Illustration of model structure for Models 1, 2 & 3. The
figure illustrates the change in infectiousness over time, for Model 1
(SEIR; top), Model 2 (Exponential decay; middle) and Model 3 (Burst;
bottom). l is the force of infection, i.e. the rate at which susceptible
individuals are recruited to the latent class, E, and e is the mean rate at
which infected individuals progress to infectiousness. The asymptom-
atic class, A, and recovered class, R, are omitted from the figure for
visual clarity.
doi:10.1371/journal.pone.0068413.g002
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Transmission models
For comparison with our alternative models, we first fit an SEIR
compartmental model [14] modified to allow for Gamma-
distributed sojourn times in the latent (E) and infectious (I) classes
(Model 1), to the outbreak data. In Model 1, infectiousness per unit
of time does not change as the infectious period progresses, but
infections may be of variable duration. We then develop two
alternate models with time-varying infectiousness. The first, Model
2, represents the change in infectiousness as exponentially
decaying over time. The other alternative model, Model 3, begins
with a sharp spike in infectiousness at onset, dropping off after the
first 12 hours of infection. This represents discontinuity in
infectiousness at the conclusion of the profuse vomiting that often
marks onset. Figure 2 illustrates differences in model structure for
Models 1, 2 & 3. Table 1 defines parameters used in Models 1–3.
We then compare the ability of each model to reproduce
characteristic features of the outbreak data. This allows us to assess
whether a model with time-varying infectiousness may provide a
more comprehensive explanation of qualitative features of NoV
transmission than standard approaches. Using a quantitative
Bayesian model comparison technique, we also compare the two
models of time-varying infectiousness to understand if one of these
representations may better explain the data.
Because asymptomatic norovirus infection is common, account-
ing for 15–40% of all norovirus infections [15], we also explore the
sensitivity of Models 2 & 3 to the presence of asymptomatic
infections. Although asymptomatic cases are unlikely to be as
infectious as symptomatic ones [16], they still may impact
transmission. Understanding these dynamics is particularly
important for quantifying the role of post-symptomatic shedding
and persistence of the virus in the environment. Specifically, long
serial intervals between symptomatic cases in a household could be
explained by either the presence of an asymptomatic case bridging
two symptomatic cases, or a long period of environmental
contamination or post-symptomatic shedding. For clarity, when
discussing the implementation of transmission models in the text,
we focus primarily on transmission to and from symptomatic cases.
For more detail on the implementation models including
asymptomatic cases, see File S1.
Model 1: SEIR compartmental model
Because the outbreak data are reported in twelve-hour intervals,
we use a discrete-time model where each model step represents a
12-hour period. We designate the time t = 0 to be when the first
individual in the household is exposed to the point source. When
t = 0, we assume that all individuals in the household are in the
susceptible state, S. The state variable S(t) represents the number
of susceptible individuals in the household at time t. We denote
wPS to be the probability that individuals who dined at the point-
source were infected there.
Upon infection, individuals enter the latent state (E). The mean
duration of latency is estimated from the outbreak data to be
1 day. We represent the latent period with a Gamma distribution
with mean e = 1 day, and shape parameter eS = 4. A shape
parameter of 4 represents moderate variability in latency, with
95% of latent periods in the range from 12–48 hours, consistent
with data reported from the outbreak [12] and other clinical and
outbreak studies [17,18]. Sensitivity analysis in which the mean
duration of latency was increased to 1.5 days did not show any
difference in results.
After latency, individuals progress to the symptomatic (I) or
asymptomatic (A) phase of infection. We assume that all
individuals in the household are equally susceptible to infection,
regardless of age, sex or household configuration. Infected
individuals will have a symptomatic infection with probabilityr
and an asymptomatic infection with probability 1-r. Asymptom-
atic infections have a fixed proportion, f, of the infectiousness of
symptomatic individuals. When fitting models to the outbreak
data, we fix f = 0.10, as only qualitative estimates of the infectivity
of asymptomatic cases are available (e.g., [8,16]) and these indicate
that they are much less infectious on a per-contact basis than
symptomatic cases. We then examine the sensitivity of the model
to variability in r, as the proportion of cases that are fully
asymptomatic is not well understood.
After latency, individuals enter either the symptomatic infec-
tious period (I) with probabilityr, or the asymptomatic infectious
period (A) with probability 1-r. In our model, household NoV
transmission is assumed to be density dependent, i.e. each
symptomatic individual transmits to each of her susceptible
Table 1. Parameters and definitions.
Model Parameter Definition Value Source
All Models wPS Probability of infection at point source – EST
f Relative infectiousness of asymptomatics 0.05 See text
r Proportion of cases asymptomatic [0.0, 0.4] Atmar et al.
2006
e Mean duration of latency 1 day See text
eS Shape parameter of latent period distribution 4 See text
Model 1 b Daily symptomatic transmission rate – EST
c Mean duration of symptomatic infectiousness – EST
cS Shape par. of infectious period duration – EST
Model 2 w2 Total infectiousness – EST
1/g2 Mean day of infectivity profile – EST
Model 3 w3 Total infectiousness – EST
1/g3 Mean day of post-onset infectivity – EST
t Proportion of infectiousness at onset – See text
The table lists parameters used in each model as well as fixed values and ranges of parameters assumed or estimated separately from the current analysis. Entries
marked ‘EST’ indicate parameters estimated in the analysis. Model-specific parameters are denoted by a subscript.
doi:10.1371/journal.pone.0068413.t001
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contacts at rate b regardless of household size. Infectious period
duration is modeled by a Gamma distribution, with parameters
cM (mean duration), and cS (shape parameter) to be estimated from
the data. For c and cSwe use Uniform prior distributions on the
range (0,100]. For b we use a Uniform prior distribution on the
range (0, 10]. We can write the force of infection on a susceptible
individual from the household transmission as l(t)~bI(t), where
I(t) is the number of symptomatic individuals in the household at
time t.
Model 2: Exponential decay of infectiousness
Model 2 introduces smooth variation in infectiousness over
time. In this model, the infectiousness of a case decays
exponentially as a function of time elapsed since the onset of
symptoms. We use a discretized exponential distribution with
mean1=g2days, denoted zExp(t,g2), where g2 is the rate parameter
of the distribution, to represent the proportion of an individual’s
infectiousness occurring at each 12-hour interval after onset,
denoted by tonset. An exponential distribution is a natural choice to
represent infectivity over the symptomatic period, because its
mode is at zero [19], i.e., the time of symptom onset. This
guarantees that the largest amount of infectiousness occurs with
the onset of symptoms. It is also a parsimonious representation of
the change in infectiousness over time, as the distribution has only
a single parameter controlling the rate of decay. So,
zExp(t{tonset; g2)is the proportion of the individual’s infectivity
that occurs during period t. This is referred to as the infectivity profile
of the case [20,21]. The total expected transmission rate over the
entire infection is denoted w, and the rate of transmission from a
case to a susceptible individual at a given time, t, is
w|zExp(t{tonset; g2).
We denote ySj to be the time of symptom onset. The force of
infection on a susceptible individual j from an infectious case, i, at




Model 3: Burst of infectiousness followed by exponential
decay
In Model 3, the infectious period consists of two phases: 1) a 12-
hour burst of infectivity starting with the onset of symptoms,
followed by 2) a period of declining infectivity modeled by an
exponential distribution with mean 1=g3, as in Model 2. The burst
in infectiousness is assumed to last for only the initial 12 hours of
the infectious period, as the majority of vomiting during naturally-
infected norovirus cases has been observed to occur in the first
24 hours after infection [15]. In addition, the onset of vomiting is
often sudden and explosive, so contact-limiting behaviors that
minimize transmission even in the presence of vomiting are likely
to be implemented in the period immediately following the initial
vomiting event. Because the sudden onset of vomiting is such a
characteristic feature of symptomatic NoV infection, Model 3 is
meant to represent the risk associated with a typical case, although
individual cases may deviate from this pattern. For example,
variation in the location, magnitude, and number of vomiting
events associated with an individual case may contribute to
between-individual heterogeneity.
Model 3 introduces a new parameter, t, which defines the
proportion of a case’s infectiousness that occurs during the
12 hour burst at onset, with the remaining 1-t occurring
afterwards. We fix t = 0.5, so that 50% of the infectiousness
occurs during the burst immediately after onset, with the
remaining half spread over a period of exponentially decaying
infectivity. This ensures that comparisons with Model 3 highlight
the differences between a model assuming that vomiting charac-
teristic of illness onset concentrates a disproportionate amount of
infectiousness at the period immediately following the start of
symptoms, and those that do not. We denote the rate of
transmission over the life of the infection as w2, and define the






(1{t)w3|zExp(t{½ySi z1; g3) otherwise
(
Data model
We fit Models 1–3 to the outbreak data using a Bayesian data
augmentation (DA) approach [20]. These methods allow us to
model outbreak data that are partially observed. Because we only
observe the time of illness onset but not infection or recovery it is
not possible to directly calculate the likelihood. DA methods allow
us to use Markov-Chain Monte Carlo (MCMC) tools to sample
from the posterior distribution of model parameters and unob-
served events (infection, recovery) in the individual’s infection
history. Sampling complete sequences of events makes the
likelihood function tractable and allows us to estimate model
parameters. This approach has previously been used to model
norovirus outbreaks [7] as well as transmission of influenza [21,22]
pneumococcus [23,24], and foot and mouth disease [25], among
other pathogens. In Model 1, there are two unobserved events
corresponding to each non-index case: the infection time and
recovery time. In Models 2 & 3, there is only one latent event per
case: the infection time.
When fitting parameters for the mean day of the infectivity
profile for Models 2 & 3 (1=g2,1=g3), we use a uniform prior on the
interval from 1–5 days. This was done to constrain the sampler to
plausible durations of infectiousness and to guard against over-
fitting of the models to households with longer serial intervals
between cases. For models 2 & 3, a Uniform prior on the range (0,
10] was used for the parameter w. When estimating parameter
values, we use the mean of the parameter’s marginal posterior
distribution. We checked these values against the corresponding
posterior median and found that our results are not sensitive to this
choice.
To understand the contribution of fully asymptomatic infec-
tions, i.e. those that enter the asymptomatic infectious phase, A,
immediately after the end of the latent period, E, we employ two
reversible jump MCMC steps (see, e.g.[23,24]) that allow us to add
and remove asymptomatic infections from the histories of non-
cases in the outbreak dataset. Because asymptomatic infections are
likely to be much less infectious than symptomatic ones, our
motivation for including them is to understand their impact on
estimates of the symptomatic transmission rate. It is not feasible to
estimate transmission parameters for asymptomatic infections
from our data because they are unlikely to emit a strong signal of
infectiousness. Consequently, we make some assumptions about
the nature of asymptomatic infections, specifically: 1) that they are
only 10% as infectious as symptomatic infections and 2) that the
mean of the infectivity profile is at 5 days. For a detailed
explanation of the application of these methods to our data, see
File S1.
Symptom Intensity and Norovirus Transmission
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All models presented here were implemented using Python 2.7.
Analysis of posterior distributions was performed using the coda
package in R 2.15. Code used in this analysis is available from the
authors upon request.
Model comparison
We compare the quality of model fit for Models 1, 2 & 3 based
on qualitative fit to the data based on descriptive statistics. We
perform Bayesian model selection using Bayes factors [21] to
compare the time-varying infectiousness models (2 & 3).
Qualitative model comparison
To make qualitative comparisons, we fix the parameters for
each model at the posterior mean values estimated from the
outbreak data and generate 104 sample outbreaks using the
household sizes and point-source exposure patterns from the
outbreak data. We then compare features of these sampled
outbreaks to the household outbreak data via several descriptive
statistics. These include: 1) the average number of secondary cases
in households with at least one secondary case, 2) the average
serial interval between household cases, 3) the average time from
onset in the first household case to onset in the last household case
in those households with secondary cases, 4) the probability of zero
observed secondary cases within the household, i.e. that the index
fails to generate any secondary cases, and 5) the probability of
recrudescence of a household outbreak, defined here as the
probability of observing a serial interval of $4 days between cases
in a household.
Quantitative model comparison
We compare the relative strength of evidence supporting these
models using Bayes factors. Bayes factors facilitate the comparison
of models with differing structure. However, the large number of
unobserved recovery times in Model 1, each represented by a
hidden parameter, makes meaningful comparison of Model 1 with
Models 2 & 3 with Bayes factors infeasible. This is because Bayes
factors naturally penalize additional model structure, effectively
guaranteeing that a model with fewer latent parameters (i.e.,
Models 2 &3) would be preferred over one with many more. So,
we limit this aspect of the analysis to the two models with varying
infectiousness over the symptomatic period. The Bayes factor, K32,
that we use to compare the models M2 & M3 is the ratio of the
posterior densities of each model, given the data, i.e.
K32~P(M3D )=P(M2D ) (see [21] & File S1).
Because we repeat this analysis for varying rates of asymptom-
atic prevalence, we denote K32(1{r) to be the Bayes factor
comparing Model 3 to Model 2, for a specific level of
asymptomatic prevalence, 1-r. We calculated Bayes factors for
each 10% increment in asymptomatic prevalence from 0% to
40%. This allows us to examine the strength of evidence in favor of
each model under different assumptions about the prevalence of
asymptomatic infections. To interpret these Bayes factors, we use
the Jeffreys scale [26], which is a subjective guide to the strength of
the evidence supporting a given hypothesis.
In order to perform this portion of the analysis, we employed a
reversible-jump MCMC sampling step that allowed the sampler to
jump between Models 2 and 3 within a single MCMC run. This
step is similar to one employed by O’Neill & Marks [10] in their
analysis of NoV transmission in a school outbreak.
When interpreting the results of these model comparisons, it is
important to note that Model 3 represents a stylized scenario in
which 50% of infectiousness is concentrated at onset. This means
that comparisons between Model 2 and 3 are necessarily heuristic
in terms of their ability to assess the explanatory power of a model
that allows excess infectivity at onset versus one that does not. So,
for example, if Model 3 is preferred over Model 2, this would
indicate that a model with 50% of infectiousness concentrated at
onset is preferred to one in which there is an exponential decay of
infectiousness beginning at onset. But it should not be taken as
evidence that a model with a spike in infectiousness at onset is
preferred in all cases, regardless of the height of this spike.
Results
Parameter estimates
Table 2 lists parameter estimates for Models 1–3 with only
symptomatic infections. For estimates over varying levels of
asymptomatic prevalence, see Tables S1 & S2 in File S1. For
descriptive characteristics of the household outbreaks, see Table 3.
Across all three models, estimates of the probability of infection
at the point source are similar, with a 55% probability of infection
for non-index cases exposed to the point source (r̂PS = 0.55, 95%
CI = 0.38, 0.71. Estimates of a secondary attack rate of
approximately 15% are also consistent across models. To test
the validity of the assumption in Model 3 that t = 0.5, i.e. that
50% of infectiousness occurs during the burst at onset and 50%
occurs afterwards, we re-fit Model 3 while allowing t to vary. We
found that the estimated value was close to the assumed value
(t3 = 0.46, 95% CI: 0.19, 0.75), while other parameter estimates
listed in Table 2 were unchanged. Sensitivity analysis using Bayes
Table 2. Parameter estimates for Models 1–3.
Model
Para
meter Model 1 Model 2 Model 3
Est 95% CI Est 95% CI Est 95% CI
All wPS 0.55 (0.38, 0.71) 0.55 (0.38, 0.71) 0.54 (0.38, 0.71)
Time
Varying
w – – 0.13 (0.07, 0.21) 0.14 (0.08, 0.22)
g – – 2.78 (1.55, 4.87) 3.89 (2.20, 4.95)
Compart
mental
b 0.05 (0.02, 0.10) – – – –
c 2.98 (1.22, 4.79) – – – –
cS 1.04 (0.07, 3.63) – – – –
doi:10.1371/journal.pone.0068413.t002
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factors was also performed in which the duration of the burst at
onset was varied from 12 to 24 hours, and both burst durations
were supported equally by the data with no impact on estimated
parameter values. Figure 3 illustrates the fitted infectivity profiles
for Models 2 and 3.
Model comparison
Table 3 presents descriptive features of the outbreak data and
corresponding measures of 104 of simulated outbreaks from
Models 1–3. The first column of Table 3 lists mean values from
the data and the ranges of these values. In Columns 2–4, is the
mean value from the simulations and values spanning the range
from the 5th to the 95th quantile of the simulated distribution of the
outcome. We find that all models reproduce mean values and
variability in the outbreak data for 1) the number of secondary
cases, 2) duration of serial intervals between cases, and 3) average
household outbreak duration. The models differ in their ability to
reproduce recrudescence and the proportion of households with
no secondary cases. The probability of recrudescence for Model 1
(0.22) and Model 3 (0.21) are closest to the data (0.17), while
Model 2 overestimates this value by a larger margin than the other
two (0.29). Simulations from Models 2 & 3 generate values for the
probability of observing no secondary cases (0.63 & 0.64,
respectively) that are closer to the data (0.62) than Model 1
(0.70). Overall, Model 3 generates values closest to the outbreak
data along those qualitative dimensions where there are differences
between the candidate models.
In our quantitative comparison of models 2 and 3, we find that in
a model with only symptomatic infections, support for Model 3 is
strong (K32(0) = 25). As asymptomatic prevalence increases from
10% to 40%, the strength of evidence in favor of Model 3 decreases,
but remains strong (K32(0:1) = 16, K32(0:2) = 14, K32(0:3) = 14,
K32(0:4) = 16). This indicates that the explanatory power of Model
3 is not sensitive to the level of asymptomatic prevalence. Sensitivity
analysis in which the infectiousness of an asymptomatic case relative
to a symptomatic case was varied from 5% to 15% did not impact
these results. Tables S1 & S2 in File S1 show parameter estimates
for models with varying levels of asymptomatic prevalence.
Tables S3 & S4 in File S1 show the robustness of the fitting
procedure to inclusion of asymptomatic infections.
Discussion
These results suggest that models including time-varying
infectiousness may better capture observed person-to-person
norovirus transmission dynamics than approaches assuming
uniform intensity of infectiousness over time. Allowing for changes
in infectiousness that reflect characteristic patterns of norovirus
illness can increase our ability to explain observed outbreak
patterns and re-create qualitative features of these outbreaks. In
particular, Models 2 & 3 were better able than Model 1 to
reproduce the proportion of household outbreaks not resulting in
secondary cases. Model 3 was also able to capture the probability
of recrudescence in household outbreaks, potentially because the
infectiousness remaining after the burst at onset is more evenly
distributed over the infectious period than in Model 2. A particular
strength of an approach allowing for symptom intensity to vary
with time is that the roles of waning symptomatology and post-
symptomatic shedding can be explored without adding model
complexity, i.e. additional infectious classes. Because it eliminates
latent state variables in the infectious period, this framework also
facilitates straightforward model comparison.
Quantitative comparisons between Models 2 and 3 suggest that
Model 3 provides a more comprehensive picture of the outbreak
data than the other models presented here. This also holds across a
range of plausible asymptomatic prevalence rates. These results
are qualified, however, by the relatively small size of this outbreak
and should be verified against datasets with a higher density of
cases. It is important to note, however, that our data actually
represent 70 independent replications of the household transmis-
sion process. In addition, the use of a dataset where an individual’s
outcomes are directly linked to her exposure is likely to decrease
error in estimation relative to approaches in which only the
aggregate force of infection and population-level incidence are
considered, (see e.g. [27]). These findings also echo results from
other modeling studies which have found that asymptomatic
infection is unlikely to play a major role in person-to-person
transmission during an outbreak [16].
Although all three models are able to explain key features of the
data, the qualitative fit of model 3 is the strongest of those
considered here. As compared to models 1 & 2, it is able to capture
both patterns of within-household transmission as well as the
probability the index case will fail to transmit to any household
members. Our findings are, however, limited by two factors.
First, the fact that our dataset consists primarily of self-reported
illness onset times may introduce some error with respect to the
actual time of infectiousness onset. Second, to provide a contrast to
models 1 & 2, in model 3 the proportion of a case’s infectivity at
onset is fixed at 50%. This means that our model comparison
results need to be interpreted as a contrast between one in which
Table 3. Descriptive characteristics of household outbreak data compared to 10̂4 simulations from fitted Models 1–3.
Data Model 1 Model 2 Model 3








(in hh w/1+ cases)
1.3 (1.0, 4.0) 1.2 (1.0, 3.0) 1.3 (1.0, 3.0) 1.3 (1.0, 3.0)
Avg household outbreak
duration (days)
3.1 (0.5, 10.0) 2.8 (0.5, 10.0) 3.4 (0.5, 11.0) 2.9 (0.5, 10.0)
Avg serial interval (days) 2.3 (0.5, 8.0) 2.6 (0.5, 8.0) 2.7 (0.6, 9.0) 2.3 (0.5, 9.5)
Probability no
secondary cases
0.62 – 0.70 – 0.63 – 0.64 –
Recrudescence
probability
0.17 – 0.22 – 0.29 – 0.21 –
doi:10.1371/journal.pone.0068413.t003
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50% of the infectiousness occurs at onset with smooth variation
thereafter to one in in which infectiousness at onset is tied
smoothly to variation afterwards, rather than a general compar-
ison between a model with a spike at onset and one in which there
is no such spike.
Consequently, although our findings suggest that it is important
to account for increased infectiousness at onset, they should be
verified and expanded using outbreak datasets with more cases
and larger contact networks. Future analysis should also address
variation in infectivity profiles by age, as this is likely to influence
transmission. In addition, data including laboratory testing
confirming symptomatic infection and identifying asymptomatic
cases is necessary to verify the robustness of these results to
asymptomatic transmission.
In model 3, we also assume that the 12-hour duration of the
burst of infectiousness following onset is similar to the period of
vomiting reported from a cohort study of norovirus infections in
the community [15]. Clinical challenge studies, e.g. [8], have
shown longer periods of vomiting of up to several days. But this
may result from dosage with quantities of norovirus much greater
than likely to be encountered in the context of a real-world
outbreak. Given the critical role of vomiting in norovirus
transmission [3,10], further study is necessary to understand the
distribution of the duration and intensity of vomiting in the context
of real-world outbreaks and the role of contact-limiting behavior in
transmission.
The methods discussed here may be extended to include the
mechanisms driving the shape of infectiousness over time. For
example, for HIV and other STIs, infectiousness over time may be
modeled as a function of individual-level covariates, such as
changes in risk behavior. Models including time-variation in the
influence that individuals have on each other might also be
usefully extended to studies of the diffusion of behavioral risks for
chronic illness, e.g. obesity [28], where compartmental modeling
approaches may result in an awkward discretization of changes in
social behavior over time.
Our results underscore the idea that public health interventions
need to focus on both the acute phase of infection as well the
environmental contamination and post-symptomatic infectious-
ness that characterize norovirus outbreaks. Onset of norovirus
gastroenteritis is often abrupt, with no prodrome, so public
vomiting events are common. Preventing such events from
occurring may not be possible, but our results demonstrate the
importance of rapidly responding to such occurrences, as well as
other opportunities for transmission in the initial phase of illness.
Future work should test this framework and its implications for
intervention in the context of community and institutional
outbreaks, where issues of sanitation are most acute.
Figure 3. Fitted infectivity profiles for Models 2 & 3. The figure shows infectiousness as a function of time since symptom onset for the
estimated values of the exponential decay model (Model 2; solid line) and burst model (Model 3; dashed line).
doi:10.1371/journal.pone.0068413.g003
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